Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication primarily associated with bisphosphonates, denosumab, and antiangiogenic agents. Dental professionals often encounter delayed healing in these patients. Diagnosis is clinical, supported by imaging when necessary. Risk stratification and preventive dental protocols are vital before initiating antiresorptive therapies.
Identifying high-risk cases early can significantly reduce morbidity. Refresh your knowledge on diagnosing medication-related osteonecrosis of the jaw (MRONJ) by taking the quick question below! Reference : Journal of Research in Medical and Dental Sciences ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information,…
